发明授权
- 专利标题: Muscarinic agonists
-
申请号: US15749957申请日: 2016-08-03
-
公开(公告)号: US10738029B2公开(公告)日: 2020-08-11
- 发明人: Giles Albert Brown , Julie Cansfield , Mark Pickworth , Benjamin Gerald Tehan , Barry John Teobald
- 申请人: Heptares Therapeutics Limited
- 申请人地址: GB Cambridge
- 专利权人: Heptares Therapeutics Limited
- 当前专利权人: Heptares Therapeutics Limited
- 当前专利权人地址: GB Cambridge
- 代理机构: McCarter & English, LLP
- 代理商 Steven G. Davis; Mei Bai
- 优先权: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@4e8de96d
- 国际申请: PCT/GB2016/052385 WO 20160803
- 国际公布: WO2017/021729 WO 20170209
- 主分类号: C07D401/14
- IPC分类号: C07D401/14 ; A61P25/28 ; A61P25/18
摘要:
This invention relates to compounds that are agonists of the muscarinic M1 receptor and/or M4 receptor and which are useful in the treatment of muscarinic M1/M4 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds include those according to formula 1 or a salt thereof, wherein q, r, s, Q, R1, R2′, R2″, R3 and R4 are as defined herein.
公开/授权文献
- US20180222885A1 MUSCARINIC AGONISTS 公开/授权日:2018-08-09
信息查询